LGT Group Foundation
Source: SEC Form 13F · as of Mar 2026LGT Group Foundation holds 18 biotech & pharma companies tracked by BioSniper, totaling $1.11B in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$1.11B
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 399,693 | $367.6M |
| AZNASTRAZENECA PLC | 1,890,121 | $367.2M |
| JNJJOHNSON & JOHNSON | 497,989 | $121.7M |
| ABBVAbbVie Inc. | 413,651 | $90.0M |
| PFEPFIZER INC | 2,206,233 | $62.0M |
| WSTWest Pharmaceutical Services Inc. | 203,556 | $51.0M |
| MRKMerck & Co., Inc. | 194,925 | $23.4M |
| ZTSZoetis Inc. | 68,088 | $8.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 26,178 | $7.1M |
| IDXXIDEXX LABORATORIES INC /DE | 3,879 | $2.2M |
| AMGNAMGEN INC | 4,884 | $1.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3,840 | $1.7M |
| BMYBRISTOL MYERS SQUIBB CO | 19,824 | $1.2M |
| MEDPMedpace Holdings Inc. | 1,522 | $731K |
| RDYDR REDDYS LABORATORIES LTD | 21,345 | $296K |
| BAXBaxter International Inc. | 17,160 | $288K |
| ABTABBOTT LABORATORIES | 2,711 | $278K |
| IQVIQVIA Holdings Inc. | 1,359 | $232K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.